vs
Acadia Healthcare Company, Inc.（ACHC）とTaylor Morrison Home Corp（TMHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Taylor Morrison Home Corpの直近四半期売上が大きい（$1.4B vs $829.0M、Acadia Healthcare Company, Inc.の約1.7倍）。Taylor Morrison Home Corpの純利益率が高く（7.1% vs 0.5%、差は6.6%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（7.5% vs -26.8%）。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い（2.0% vs -16.5%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
テイラー・モリソン・ホーム社は米国最大級の住宅建設会社で、本社はアリゾナ州スコッツデールに所在します。2007年7月にテイラー・ウッドローとモリソン・ホームズが合併して設立され、アリゾナ、カリフォルニア、テキサスなど10以上の州で事業を展開し、初回購入向け、中間層向け、中高級層向けの多様な住宅を提供しています。
ACHC vs TMHC — 直接比較
損益計算書 — Q1 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $1.4B |
| 純利益 | $4.5M | $98.6M |
| 粗利率 | — | 21.0% |
| 営業利益率 | — | — |
| 純利益率 | 0.5% | 7.1% |
| 売上前年比 | 7.5% | -26.8% |
| 純利益前年比 | -50.8% | -53.8% |
| EPS（希薄化後） | $0.05 | $1.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | $1.4B | ||
| Q4 25 | $821.5M | $2.1B | ||
| Q3 25 | $851.6M | $2.1B | ||
| Q2 25 | $869.2M | $2.0B | ||
| Q1 25 | $770.5M | $1.9B | ||
| Q4 24 | $774.2M | $2.4B | ||
| Q3 24 | $815.6M | $2.1B | ||
| Q2 24 | $796.0M | $2.0B |
| Q1 26 | $4.5M | $98.6M | ||
| Q4 25 | $-1.2B | $174.0M | ||
| Q3 25 | $36.2M | $201.4M | ||
| Q2 25 | $30.1M | $193.6M | ||
| Q1 25 | $8.4M | $213.5M | ||
| Q4 24 | $32.6M | $242.5M | ||
| Q3 24 | $68.1M | $251.1M | ||
| Q2 24 | $78.5M | $199.5M |
| Q1 26 | — | 21.0% | ||
| Q4 25 | — | 22.0% | ||
| Q3 25 | — | 22.7% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | — | 24.4% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 23.7% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | — |
| Q1 26 | 0.5% | 7.1% | ||
| Q4 25 | -143.3% | 8.3% | ||
| Q3 25 | 4.3% | 9.6% | ||
| Q2 25 | 3.5% | 9.5% | ||
| Q1 25 | 1.1% | 11.3% | ||
| Q4 24 | 4.2% | 10.3% | ||
| Q3 24 | 8.4% | 11.8% | ||
| Q2 24 | 9.9% | 10.0% |
| Q1 26 | $0.05 | $1.12 | ||
| Q4 25 | $-12.98 | $1.77 | ||
| Q3 25 | $0.40 | $2.01 | ||
| Q2 25 | $0.33 | $1.92 | ||
| Q1 25 | $0.09 | $2.07 | ||
| Q4 24 | $0.36 | $2.29 | ||
| Q3 24 | $0.74 | $2.37 | ||
| Q2 24 | $0.85 | $1.86 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $652.9M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $6.2B |
| 総資産 | $5.5B | $9.8B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | $652.9M | ||
| Q4 25 | $133.2M | $850.0M | ||
| Q3 25 | $118.7M | $370.6M | ||
| Q2 25 | $131.4M | $130.2M | ||
| Q1 25 | $91.2M | $377.8M | ||
| Q4 24 | $76.3M | $487.2M | ||
| Q3 24 | $82.1M | $256.4M | ||
| Q2 24 | $77.2M | $246.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | $2.3B | $2.2B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.2B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.2B |
| Q1 26 | $2.0B | $6.2B | ||
| Q4 25 | $1.9B | $6.3B | ||
| Q3 25 | $3.1B | $6.2B | ||
| Q2 25 | $3.1B | $6.1B | ||
| Q1 25 | $3.0B | $6.0B | ||
| Q4 24 | $3.1B | $5.9B | ||
| Q3 24 | $3.0B | $5.7B | ||
| Q2 24 | $3.0B | $5.5B |
| Q1 26 | $5.5B | $9.8B | ||
| Q4 25 | $5.5B | $9.8B | ||
| Q3 25 | $6.4B | $9.6B | ||
| Q2 25 | $6.3B | $9.5B | ||
| Q1 25 | $6.1B | $9.4B | ||
| Q4 24 | $6.0B | $9.3B | ||
| Q3 24 | $5.9B | $9.3B | ||
| Q2 24 | $5.7B | $9.1B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.36× | ||
| Q3 25 | 0.74× | 0.35× | ||
| Q2 25 | 0.74× | 0.35× | ||
| Q1 25 | 0.72× | 0.35× | ||
| Q4 24 | 0.64× | 0.36× | ||
| Q3 24 | 0.62× | 0.37× | ||
| Q2 24 | 0.62× | 0.39× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | — |
| フリーキャッシュフロー営業CF - 設備投資 | — | — |
| FCFマージンFCF / 売上 | — | — |
| 設備投資強度設備投資 / 売上 | — | — |
| キャッシュ転換率営業CF / 純利益 | 13.78× | — |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $646.4M | ||
| Q3 25 | $73.2M | $219.6M | ||
| Q2 25 | $133.5M | $-126.0M | ||
| Q1 25 | $11.5M | $77.2M | ||
| Q4 24 | $116.7M | $438.2M | ||
| Q3 24 | $163.1M | $135.9M | ||
| Q2 24 | $171.1M | $-233.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $635.3M | ||
| Q3 25 | $-63.0M | $206.6M | ||
| Q2 25 | $-34.2M | $-133.6M | ||
| Q1 25 | $-163.2M | $68.7M | ||
| Q4 24 | $-86.8M | $428.2M | ||
| Q3 24 | $-27.1M | $127.1M | ||
| Q2 24 | $16.9M | $-241.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 30.3% | ||
| Q3 25 | -7.4% | 9.9% | ||
| Q2 25 | -3.9% | -6.6% | ||
| Q1 25 | -21.2% | 3.6% | ||
| Q4 24 | -11.2% | 18.2% | ||
| Q3 24 | -3.3% | 6.0% | ||
| Q2 24 | 2.1% | -12.1% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.5% | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 0.4% | ||
| Q1 25 | 22.7% | 0.4% | ||
| Q4 24 | 26.3% | 0.4% | ||
| Q3 24 | 23.3% | 0.4% | ||
| Q2 24 | 19.4% | 0.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.71× | ||
| Q3 25 | 2.02× | 1.09× | ||
| Q2 25 | 4.43× | -0.65× | ||
| Q1 25 | 1.37× | 0.36× | ||
| Q4 24 | 3.58× | 1.81× | ||
| Q3 24 | 2.39× | 0.54× | ||
| Q2 24 | 2.18× | -1.17× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
TMHC
| Home closings revenue, net | $1.3B | 95% |
| Financial services revenue, net | $49.3M | 4% |
| Land closings revenue | $14.5M | 1% |
| Amenity and other revenue | $11.9M | 1% |
